XML 38 R15.htm IDEA: XBRL DOCUMENT
v3.25.2

COMMON STOCK | 12 Months Ended
--- | ---
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract] |
COMMON STOCK | COMMON STOCK In the fiscal year ended March 31, 2023, the Company’s stockholders approved an increase in its authorized shares of common stock from 125 million to 225 million. Long-Term Incentive Plan The Company maintains two stockholder-approved incentive plans, the 2012 Long-Term Incentive Plan (the "2012 Plan") and the 2023 Long-Term Incentive Plan (the “2023 LTIP”). The 2023 LTIP serves as the successor to the Company’s 2012 Plan and provides for grants of performance share units, restricted stock units and stock options. On August 15, 2024, the stockholders of the Company approved an additional 250,000 shares of Common Stock under the 2023 LTIP for future issuance. Equity awards typically vest between one and three years. Stock options, performance shares and restricted stock grants to non-employee directors typically vest over one year. The term of each stock option under the 2023 Plan will not exceed seven years. Stock options, performance share units and restricted stock units granted under the 2023 Plan are subject to forfeiture if employment terminates. The 2023 Plan has 0.7 million shares authorized for issuance of new shares, with 0.5 million performance shares and restricted shares outstanding, and 0.1 million shares available for future issuance under the Plan as of March 31, 2025. 2021 Inducement Plan The Company's 2021 Inducement Plan (the "2021 Inducement Plan") became effective on February 1, 2021 and provides for issuance of inducement equity awards to individuals who were not previously an employee or non- employee director of the Company as an inducement material to such individual's entering into employment with the Company. The term of each stock option and restricted stock unit under the plan will not exceed seven years, and each award generally vests between two and three years. On December 30, 2022 the Leadership and Compensation Committee of the Board of Directors approved an amendment to the 2021 Inducement Plan to increase the number of shares of common stock of the Company authorized for issuance thereunder from 38,500 to 0.1 million. There were 38,380 shares available for future issuance as of March 31, 2025. The Company accounts for all forfeitures of stock-based awards when they occur. Employee Stock Purchase Plan The Company's has an Employee Stock Purchase Plan (the "ESPP") which enables eligible employees to purchase shares of its common stock at a discount. Purchases will be accomplished through participation in discrete offering periods. On each purchase date, eligible employees will purchase the Company's common stock at a price per share equal to 85% of the lesser of (i) the fair market value of the Company's common stock on the first trading day of the offering period, and (ii) the fair market value of the Company's common stock on the purchase date. The Company has reserved shares of common stock for future issuance under its ESPP as follows (in thousands):
| March 31,
| 2025 |  | 2024 |  |
Shares available for issuance at beginning of period | 4.4 |  |  | 4.4 |  |  |
Shares issued during the period | 200 |  |  | — |  |  |
Total shares available for future issuance at end of period | 204.4 |  |  | 4.4 |  |  |
Performance Stock Units The Company granted 0 and 6,000 shares of performance share units with market conditions (“Market PSUs”) in fiscal 2025 and 2024, respectively. Market PSUs vest one to three years from the issuance date and become eligible for vesting based on the Company achieving certain stock price targets and are contingent upon continued service of the holder of the award during the vesting period. The estimated fair value of these Market PSUs is determined at the issuance date using a Monte Carlo simulation model. Assumptions used in the Monte Carlo model to calculate fair values of market PSU’s during each fiscal period are as follows:
Weighted-Average |  | 2025 |  | 2024 |  |
Discount period (years) |  | n/a |  | 3.00 |  |
Risk-free interest rate |  | n/a |  | 3.53% |  |
Stock price volatility |  | n/a |  | 80.50% |  |
Grant date fair value |  | n/a |  | $18.20 |  |
The Company granted 180,126 and 46,000 units of performance share units with financial performance conditions (“Performance PSUs”) in the fiscal years ended March 31, 2025 and 2024, respectively. Performance PSUs become eligible for vesting based on the Company achieving certain financial performance targets, and are contingent upon continued service of the holder of the award during the vesting period. Performance PSUs are valued at the market closing share price on the date of grant and compensation expense for Performance PSUs is recognized when it is probable that the performance conditions will be achieved. Compensation expense recognized related to Performance PSUs is reversed if the Company determines that it is no longer probable that the performance conditions will be achieved. The following table summarizes activity for Market PSUs and Performance PSUs for the year ended March 31, 2025 (shares in thousands):
| Shares |  | Weighted-Average Grant Date Fair Value per Share
Outstanding as of March 31, 2024 | 59 |  |  | $ | 18.59 |
Granted | 180 |  |  | $ | 4.71 |
Vested | (13) |  |  | $ | 28.90 |
Forfeited or cancelled | (13) |  |  | $ | 8.82 |
Outstanding as of March 31, 2025 | 213 |  |  | $ | 6.87 |
As of March 31, 2025, there was $0.8 million of unrecognized stock-based compensation related to Market PSUs and Performance PSUs, which is expected to be recognized over a weighted-average period of 1.5 years. The total grant date fair value of shares vested during fiscal years ended March 31, 2025 and 2024 was $0.4 million and $1.0 million, respectively. Restricted Stock Units The Company granted 312,250 and 60,000 of service-based restricted stock units (“RSUs”) in the fiscal years ended March 31, 2025 and 2024, respectively, which generally vest ratably over a three-year service period. RSUs are valued at the market closing share price on the date of grant and compensation expense for RSUs is recognized ratably over the applicable vesting period. The following table summarizes activity for restricted stock units for the year ended March 31, 2025 (shares in thousands):
| Shares |  | Weighted-Average Grant Date Fair Value per Share
Outstanding as of March 31, 2024 | 152 |  |  | $ | 41.06 |
Granted | 312 |  |  | $ | 4.99 |
Vested | (118) |  |  | $ | 31.98 |
Forfeited or cancelled | (19) |  |  | $ | 17.39 |
Outstanding as of March 31, 2025 | 327 |  |  | $ | 11.32 |
The total grant date fair value of RSUs vested during fiscal years ended March 31, 2025 and 2024 was $3.8 million and $6.4 million, respectively. As of March 31, 2025, there was $1.5 million of total unrecognized stock-based compensation related to RSUs, which is expected to be recognized over a weighted-average period of 1.3 years. Compensation Expense The following table details the Company's stock-based compensation expense (in thousands):
| Year Ended March 31,
| 2025 |  | 2024 |  |
Cost of revenue | $ | 373 |  |  | $ | 774 |  |  |
Research and development | 495 |  |  | 1,091 |  |  |
Sales and marketing | 317 |  |  | 669 |  |  |
General and administrative | 1,643 |  |  | 2,187 |  |  |
Total stock-based compensation | $ | 2,828 |  |  | $ | 4,721 |  |  |
| Year Ended March 31,
| 2025 |  | 2024 |  |
Restricted stock units | $ | 2,515 |  |  | $ | 4,551 |  |  |
Performance share units | 313 |  |  | 170 |  |  |
Total stock-based compensation | $ | 2,828 |  |  | $ | 4,721 |  |  |
Warrants In connection with various debt refinancing and debt amendment activities, the Company issued warrants to purchase shares of the Company common stock (the "Lender Warrants"). As of March 31, 2024 there were Lender Warrants that were issued in December 2018 which were exercisable until December 27, 2028 (the "December 2018 Warrants), issued in June 2020 which were exercisable until June 16, 2030 (the "June 2020 Warrants") and issued in June 2023 which were exercisable until June 1, 2033 (the "June 2023 Warrants"). The exercise price and the number of shares underlying the Lender Warrants were subject to adjustment in the event of specified events, including dilutive issuances of equity instruments at a price lower than the exercise price of the respective warrants (the "Down Round Feature"), repricing of existing equity-linked instruments at a price lower than the exercise price of the respective warrants (the "Warrant Repricing Feature"), a subdivision or combination of the common stock, a reclassification of the common stock or specified dividend payments. Upon exercise, the aggregate exercise price was paid, at each warrant holder’s election, in cash or on a net issuance basis, based upon the fair market value of the common stock at the time of exercise. The Company's warrants also had a provision that determines the potential stock price used when applying the Black-Scholes valuation model to determine the settlement price of the warrants in Successor Major Transactions ("SMT"), as defined in the respective warrant agreements, which include a change in control or liquidation (the "Warrant Settlement Price Provision"). The Warrant Settlement Price Provision required the use of the greater of the closing price of the Company's common stock on the trading day immediately preceding the date on which an SMT is consummated, the closing market price of the Company's common stock following the first public announcement of an SMT or the closing market of the Company's common stock immediately preceding the announcement of an SMT. Because of these terms, equity classification was precluded, and these warrants were carried as liabilities at fair value. The Company uses Level 2 inputs for its valuation methodology for the warrant liabilities as their fair values were determined by using the Black-Scholes model based on various assumptions. The assumptions used in calculating fair values of the Lender Warrants are as follows:
|  | December 2018 Warrants |  | June 2020 Warrants |  | June 2023 Warrants |  |  |  |  |  |  |  |  |  |
March 31, 2024: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Discount period (years) |  | 4.7 years |  | 6.2 years |  | 9.2 years |  |  |  |  |  |  |  |  |  |
Risk-free interest rate |  | 4.19% |  | 4.16% |  | 4.16% |  |  |  |  |  |  |  |  |  |
Stock price volatility |  | 87.00% |  | 86.00% |  | 81.00% |  |  |  |  |  |  |  |  |  |
Exercise price |  | $6.60 |  | $6.00 |  | $9.00 |  |  |  |  |  |  |  |  |  |
The Company has adopted ASC 2017-11, Earnings per share (Topic 260) ; Distinguishing liabilities from equity (Topic 480); and Derivatives and hedging (Topic 718) ("ASC 2017-11") which provides guidance that the inclusion of certain anti-dilution provisions including down-round provisions in which the exercise price and number of shares underlying an equity-linked instrument are adjusted based on certain specified events does not preclude an instrument from being equity classified. The Company has concluded the Warrant Repricing Feature does not meet the definition of a down-round provision that would provide a scope exception allowing equity classification; therefore, the Company's warrants are required to be classified as liabilities. In addition, the Company has concluded that the use of the greater of three share price inputs to the Black-Scholes valuation model in the Warrant Settlement Price Provision precludes the warrants from being indexed to the Company's own common stock under Topic 815 therefore requiring the Company to classify the warrants as liabilities with changes in fair value being recognized in the Company’s consolidated statement of operations. On December 30, 2024, 467,248 warrants were exercised in a cashless exercise whereby 61,270 shares with a value of $6.20 per share were used to settle the exercise price and the remaining 405,978 shares were issued to the warrant holders. On January 3, 2025, certain PIMCO-managed entities exercised 677,905 warrants in a cashless exercise whereby 228,195 shares with a weighted-average value of $35.42 per share were used to settle the exercise price and the remaining 449,710 shares were issued to the warrant holders. As PIMCO was a related party, this transaction was reviewed and approved in accordance with the Company’s related party transaction policy. The table below sets forth a summary of changes in the fair value of the Company’s Level 2 warrant liabilities for the years ended March 31, 2024 and March 31, 2025:
Balance at March 31, 2023 | $ | 7,989 |  |  |  |  |  |  |  |  |
Issuance of warrants | 1,194 |  |  |  |  |  |  |  |  |
Change in fair value of warrant liabilities | (5,137) |  |  |  |  |  |  |  |  |
Balance at March 31, 2024 | $ | 4,046 |  |  |  |  |  |  |  |  |
Issuance of warrants | 3,157 |  |  |  |  |  |  |  |  |
Exercise of warrants | (52,985) |  |  |  |  |  |  |  |  |
Repricing adjustment | 512 |  |  |  |  |  |  |  |  |
Change in fair value of warrant liabilities | 45,270 |  |  |  |  |  |  |  |  |
Balance at March 31, 2025 | $ | — |  |  |  |  |  |  |  |  |
The Company had no outstanding Lender Warrants as at March 31, 2025. The following table summarizes the Company's outstanding Lender Warrants as at March 31, 2024 (in thousands, except exercise price):
| December 2018 Warrants |  | June 2020 Warrants |  | June 2023 Warrants |  |  |  | Total
March 31, 2024: |  |  |  |  |  |  |  |  |
Exercise price | $ | 26.60 |  |  | $ | 55.40 |  |  | $ | 20.00 |  |  |  |  |
Number shares under warrant(s) | 357 |  |  | 184 |  |  | 63 |  |  |  |  | 604 |
Fair value | $ | 2,320 |  |  | $ | 1,135 |  |  | $ | 591 |  |  |  |  | $ | 4,046 |
The Company also issued 2,500 warrants to purchase the Company's common stock in June 2020 and June 2023 to advisors of the Company at an exercise price of $60.00 and $20.00, respectively (collectively the "Other Warrants"). The Company has concluded that the Other Warrants do not contain provisions that would require liability classification under Topic 480 or Topic 718 and have been equity classified. Standby Equity Purchase Agreement On January 25, 2025, the Company entered into a SEPA in which pursuant to and subject to its terms, the Company has the right, but not the obligation, to sell up to $200 million of Common Stock at any time during the three-year period following the date of the SEPA. On January 27, 2025, the Company filed a registration statement on Form S-1 in connection with the SEPA. The Registration Statement on Form S-1 was declared effective February 11, 2025. As of March 31, 2025, the Company has issued approximately 1.2 million shares of Common Stock under the SEPA for net proceeds of approximately $16.4 million. Registration Rights Agreements The Lender Warrants grant the holders certain registration rights for the shares of common stock issuable upon the exercise of the applicable warrants, including (a) the ability of a holder to request that the Company file a Form S-1 registration statement with respect to at least 40% of the registrable securities held by such holder as of the issuance date of the applicable warrants; (b) the ability of a holder to request that the Company file a Form S-3 registration statement with respect to outstanding registrable securities if at any time the Company is eligible to use a Form S-3 registration statement; and (c) certain piggyback registration rights related to potential future equity offerings of the Company, subject to certain limitations.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration